Salarvand, Shahin and Hemati, Simin and Adibi, Payman and Taleghani, Fariba (2018) The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy: A review. Oncology Reviews, 12 (359). pp. 129-133.
|
Text
The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy A review..pdf Download (178kB) | Preview |
Abstract
Chemotherapy-induced peripheral neuropathy is a common adverse effect occurring in patients undergoing neurotoxic chemotherapy. However, there is no FDA-approved treatment option for it. Given the importance of clinical practice guidelines in this area, this study aimed to determine the methodological quality of extant CIPN guidelines. The study was done as part of the adaptation process of CIPN related CPGs at Isfahan University of Medical Sciences, Iran. A systematic search of published CPGs about chemotherapy-induced CIPN in which the AGREE II instrument was applied for appraising CPGs of CIPN was performed. In general, amongst all of the AGREE II Instrument's domains in the evaluated CPGs, the clarity of presentation and stakeholder involvement domains took favorable scores; and other domains obtained unfavorable and relatively favorable scores. The quality of cancer therapy-induced neuropathy CPGs needs to be improved and designing high-quality CPGs must be considered.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Faculty of Medicine, Health and Life Sciences > School of Medicine |
| Depositing User: | lorestan university |
| Date Deposited: | 27 Nov 2018 05:35 |
| Last Modified: | 27 Nov 2018 05:35 |
| URI: | http://eprints.lums.ac.ir/id/eprint/1473 |
Actions (login required)
 |
View Item |
